메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Seo Il-bok (Semyung University Jecheon Republic of Korea) Ahn Sang-hyun (Semyung University Jecheon Republic of Korea)
저널정보
J-INSTITUTE Kinesiology Kinesiology Vol.5 No.1
발행연도
2020.1
수록면
58 - 64 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Bone mass is regulated by bone resorption(osteoclast) and bone formation(osteoblast), and an imbalance between both processes results in osteoporosis. Osteoporosis is characterized by a loss of bone density and regulation of bone remodeling is crucial for the treatment of osteoporosis. In this study, we investigated whether SMO16, a Korean polyherbal medicine containing 5 herbal components, could regulate bone remodeling in an ovariectomized(OVX) rat model. To test the effect of SMO16 in the OVX model, the rats were divided into 3 groups: a control group, OVX group, and OVX + SMO16(2.25 g/kg) for 8 weeks(ST group). The expression of osteocalcin(OPC), receptor activator of nuclear factor kappa-B ligand(RANKL), and osteoprotegerin(OPG) were measured in the femur using specific antibodies. The bone mass was analyzed using dual-energy X-ray absorptiometry. In the OVX group, protein expression of OPC was decreased; however, in the ST group, OPC expression was significantly increased when compared with the OVX group. SMO16 significantly reduces RANKL-positive cells in the OVX rat femur. Additionally, SMO16 increased OPG expression levels. Importantly, SMO16 significantly increased bone density. These data suggest that SMO16 increases bone remodeling by regulating OPC, RANKL, and OPG signaling. SMO16 could be a potential alternative treatment for osteoporosis.

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0